Related references
Note: Only part of the references are listed.Migration of tumor antigen-pulsed dendritic cells after mucosal administration in the human upper respiratory tract
Shigetoshi Horiguchi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Combined natural killer T-cell-based immunotherapy eradicates established tumors in mice
Michele W. L. Teng et al.
CANCER RESEARCH (2007)
Combination antibody-based cancer immunotherapy
Kazuyoshi Takeda et al.
CANCER SCIENCE (2007)
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer
Shinichiro Motohashi et al.
CLINICAL CANCER RESEARCH (2006)
Dendritic cell maturation by CD11c- T cells and Vα24+ natural killer T-cell activation by α-galactosylceramide
E Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Increased intratumor Vα24-positive natural killer T cells:: A prognostic factor for primary colorectal carcinomas
T Tachibana et al.
CLINICAL CANCER RESEARCH (2005)
CD1d ligation on human monocytes directly signals rapid NF-κB activation and production of bioactive IL-12
SC Yue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peripheral blood IFN-γ-secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load
JW Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
A Ishikawa et al.
CLINICAL CANCER RESEARCH (2005)
Expansion of human Vα24+ NKT cells by repeated stimulation with KRN7000
PR Rogers et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
M Nieda et al.
BLOOD (2004)
The immunoregulatory role of CD1d-restricted natural killer T cells in disease
HJJ van der Vliet et al.
CLINICAL IMMUNOLOGY (2004)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The characteristics of human NKT cells in lung cancer - CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients
J Konishi et al.
HUMAN IMMUNOLOGY (2004)
CD1: Antigen presentation and T cell function
M Brigl et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion
KM Dhodapkar et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2003)
Severe and selective deficiency of interferon-γ-producing invariant natural killer T cells in patients with myelodysplastic syndromes
S Fujii et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Janus-like role of regulatory inkt cells in autoimmune disease and tumour immunity
SB Wilson et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Detection and activation of human Vα24+ natural killer T cells using α-galactosyl ceramide-pulsed dendritic cells
S Fujii et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Preserved IFN-α production of circulating Vα24 NKT cells in primary lung cancer patients
S Motohashi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Human peripheral blood Vα24+ Vβ11+ NKT cells expand following administration of α-galactosylceramide-pulsed dendritic cells
M Okai et al.
VOX SANGUINIS (2002)
Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
S Fujii et al.
NATURE IMMUNOLOGY (2002)
Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide
K Yanagisawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Cutting edge:: Analysis of human Vα24+CD8+ NK T cells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells
T Takahashi et al.
JOURNAL OF IMMUNOLOGY (2002)
Expansion of lung Vα14 NKT cells by administration of α-galactosylceramide-pulsed dendritic cells
Y Akutsu et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
JE Gumperz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Distinct functional lineages of human Vα-24 natural killer T cells
PT Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
MJ Smyth et al.
BLOOD (2002)
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
LS Metelitsa et al.
JOURNAL OF IMMUNOLOGY (2001)
TRAIL expression by activated human CD4+Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells
M Nieda et al.
BLOOD (2001)